Keywords: EU, EFPIA, Competitiveness, Transparency Directive, Cost-control, Price levels, Innovation

Patient access and industry competitiveness at stake in EU Transparency Directive review, says EFPIA

Article | 26 May 2011

With the review of the European Union’s Transparency Directive (Directive 89/105/EEC) gaining momentum, improving the competitive environment for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in